Siga Technologies (SIGA) Interest & Investment Income (2012 - 2025)
Siga Technologies (SIGA) posted Interest & Investment Income of $1.9 million for Q3 2025, up 16.72% on a QoQ basis from $1.6 million in Q2 2025, and up 40.08% year-over-year from $1.3 million in Q3 2024.
Siga Technologies (SIGA) Interest & Investment Income (2012 - 2025) Analysis & Trends
Siga Technologies' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $1.9 million for Q3 2025.
- Quarterly Interest & Investment Income rose 40.08% year-over-year to $1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.7 million (up 44.77% YoY) and the FY2024 annual result came in at $6.1 million, up 46.59% from the prior year.
- Interest & Investment Income was $1.9 million for Q3 2025 at Siga Technologies, up from $1.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q1 2024 and bottomed at $1.3 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2012 | 4,067.00 |
| Mar 31, 2012 | -4,067.00 |